Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.
2.

Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.

Kim H, Moon HW, Hur M, Yun YM, Lee MH.

Acta Haematol. 2011;125(4):237-41. doi: 10.1159/000323425. Epub 2011 Feb 12. Review.

PMID:
21325813
3.

Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?

Marcucci G, Caligiuri MA, Bloomfield CD.

Eur J Haematol. 2003 Sep;71(3):143-54. Review.

PMID:
12930314
4.

RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.

De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Morel F, FĂ©rec C, De Braekeleer M.

Cancer Genet Cytogenet. 2008 Aug;185(1):47-50. doi: 10.1016/j.cancergencyto.2008.04.011. Review.

PMID:
18656694
5.
6.

Acute myeloid leukemia with t(16;21)(q24;q22) and eosinophilia: case report and review of the literature.

Park IJ, Park JE, Kim HJ, Jung HJ, Lee WG, Cho SR.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):105-8. doi: 10.1016/j.cancergencyto.2009.08.017. Review.

PMID:
19963144
7.

Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.

Giles FJ, Kanemaki TJ, Schreck RR, Qasabian L, Fuerst MP, Lim SW.

Cancer Genet Cytogenet. 1998 Jul 1;104(1):66-9. Review.

PMID:
9648562
8.

A complex variant t(8;21) involving chromosome 3 in a child with acute myeloblastic leukemia with eosinophilia (AML M4Eo).

Mathew S, Shurtleff S, Ribeiro RC, Behm FG, Raimondi SC.

Leuk Lymphoma. 2003 Jan;44(1):183-7. Review.

PMID:
12691161
9.

A rare cytogenetic presentation of acute myeloid leukemia (AML-M2).

Kumari P, LingappaKavitha B, Obula Reddy C, Mangalagowri M, Madhumathi DS, Mahadeva Prasad M, Raghavendra HV, Premalata CS, Lakshmaiah KC, Mir Mazloumi SH.

Acta Med Iran. 2012;50(12):827-30. Review.

10.

Core binding factor acute myeloid leukemia.

Paschka P.

Semin Oncol. 2008 Aug;35(4):410-7. doi: 10.1053/j.seminoncol.2008.04.011. Review.

PMID:
18692691
11.

Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.

Ferrara F, Del Vecchio L.

Haematologica. 2002 Mar;87(3):306-19. Review.

12.

The 8;21 translocation in leukemogenesis.

Peterson LF, Zhang DE.

Oncogene. 2004 May 24;23(24):4255-62. Review.

PMID:
15156181
13.
14.

AML-1-ETO-Mediated erythroid inhibition: new paradigms for differentiation blockade by a leukemic fusion protein.

Choi Y, Elagib KE, Goldfarb AN.

Crit Rev Eukaryot Gene Expr. 2005;15(3):207-16. Review.

PMID:
16390317
15.

8;21 translocation and multilineage involvement.

Kwong YL, Ching LM, Liu HW, Lee CP, Pollock A, Chan LC.

Am J Hematol. 1993 Jul;43(3):212-6. Review.

PMID:
8352238
16.

Core-binding factor acute myeloid leukemia.

Sangle NA, Perkins SL.

Arch Pathol Lab Med. 2011 Nov;135(11):1504-9. doi: 10.5858/arpa.2010-0482-RS. Review.

PMID:
22032582
17.

t(16;21)(q24;q22) in acute myeloid leukemia: case report and review of the literature.

Boils CL, Mohamed AN.

Acta Haematol. 2008;119(2):65-8. doi: 10.1159/000117710. Epub 2008 Feb 22. Review. No abstract available.

PMID:
18285693
18.

Translocation t(8;21)(q22;q22): cytogenetics and molecular biology.

Berger R.

Nouv Rev Fr Hematol. 1994;36 Suppl 1:S67-9. Review.

PMID:
8177719
19.

[Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].

Ouyang M, Xu LP, Wang Y, Zhu HH, Qin YZ, Lai YY, Liu YR, Jiang B, Huang XJ, Jiang H.

Zhonghua Xue Ye Xue Za Zhi. 2016 Mar;37(3):210-5. doi: 10.3760/cma.j.issn.0253-2727.2016.03.007. Review. Chinese.

PMID:
27033758
20.

AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer.

La Starza R, Sambani C, Crescenzi B, Matteucci C, Martelli MF, Mecucci C.

Haematologica. 2001 Feb;86(2):212-3. Review. No abstract available.

Supplemental Content

Support Center